Clin2
NCT05670951Possibly a fitRecruiting

Drug ELGN-2112 for gut absorption problems in preterm babies

Intestinal Malabsorption

Part of Digestive system, Hormones & metabolism clinical trials.

This Phase 3 trial tests whether ELGN-2112 helps preterm babies absorb food from the intestines. It aims to improve intestinal malabsorption and check safety.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
360 people
Ages
1 day to 5 days
Study type
Interventional

Who can take part

  • Baby was born early, between 26 and 32 weeks of pregnancy
  • The pregnancy age estimate from mom’s dates and/or early ultrasound matches within about 2 weeks
  • Baby weighs at least 500 grams at birth
  • Baby is born as a single baby or a twin
  • No listed exclusion conditions in the provided criteria

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05904626Recruiting· Phase 2
ELGN-2112 safety study for very preterm and small babies

This Phase 2 trial studies whether ELGN-2112 is safe in babies born very early or smaller than expected before birth. It may help doctors understand how to better care for these high-risk newborns.

Netanya
NCT07402083Recruiting
Testing a treatment from donor breast milk for early preterm babies

This trial studies a treatment made from special particles in donor breast milk, given to very early-born babies who are at risk of a serious gut infection called NEC. It aims to see if these particles can help protect their intestines.

Valencia, Valencia
NCT07088302Recruiting
Lactase enzyme for feeding intolerance in preterm babies

This trial tests if giving lactase enzyme supplements helps preterm babies (born at or before 32 weeks) tolerate their feedings better. If your baby was born early and started feeding within the first few days of life, this study may be a good fit.

Alexandria
NCT07150884Recruiting
Lactase supplement study for weight gain in preterm infants

This trial tests whether giving lactase (a natural enzyme that helps digest milk sugar) to preterm babies helps them gain weight better. It is for infants born between 28 and 34 weeks of pregnancy who get most of their nutrition through the gut.

Thessaloniki
NCT07242508Not yet recruiting
New formula for baby gut health

This trial tests a new infant formula to see if it helps babies' digestion and overall gut health. The formula is the only food the baby gets during the study.

NCT07537686Not yet recruiting· Phase 2
GLP-2 Treatment for Gut Health in Undernourished Women

This study tests whether a medication called GLP-2 (given as daily injections for one month) can help repair gut damage and improve nutrition in underweight women. You would also receive food and vitamin supplements, and have two small procedures to check your gut health.

Hear when a new Intestinal Malabsorption trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.